Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-31T15:15:07.678Z Has data issue: false hasContentIssue false
  • English
  • Français

22q11.2 deletion carriers and schizophrenia-associated novel variants

Published online by Cambridge University Press:  02 January 2018

S. Balan ,
Y. Iwayama ,
T. Toyota ,
M. Toyoshima ,
M. Maekawa  and
T. Yoshikawa
S. Balan
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
Y. Iwayama
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
T. Toyota
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
M. Toyoshima
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
M. Maekawa
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
T. Yoshikawa*
Affiliation:
Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama, Japan
*
Takeo Yoshikawa, MD, PhD, Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-city, Saitama 351-0198, Japan. Email: [email protected]
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The penetrance of schizophrenia risk in carriers of the 22q11.2 deletion is high but incomplete, suggesting the possibility of additional genetic defects. We performed whole exome sequencing on two individuals with 22q11.2 deletion, one with schizophrenia and the other who was psychosisfree. The results revealed novel genetic variants related to neuronal function exclusively in the person with schizophrenia (frameshift: KAT8, APOH and SNX31; nonsense: EFCAB11 and CLVS2). This study paves the way towards a more complete understanding of variant dose and genetic architecture in schizophrenia.

Type
Short reports
Information
The British Journal of Psychiatry , Volume 204 , Issue 5 , May 2014 , pp. 398 - 399
Copyright
Copyright © Royal College of Psychiatrists, 2014 

Footnotes

This study was supported in part by Grants-in-Aid for Scientific Research, and by Grant-in-Aid for Scientific Research on Innovative Areas, from the JSPS of Japan. In addition, this study was supported by RIKEN Brain Science Institute Funds. A portion of this study is the result of the ‘Development of biomarker candidates for social behavior’ project, carried out under the Strategic Research Program for Brain Sciences by the MEXT ministry of Japan.

Declaration of interest

None.

References

1 Philip, N, Bassett, A. Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav Genet 2011; 41: 403–12.CrossRefGoogle ScholarPubMed
2 Hiroi, N, Takahashi, T, Hishimoto, A, Izumi, T, Boku, S, Hiramoto, T. Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. Mol Psychiatry 2013; 18: 1153–65.Google Scholar
3 Toyosima, M, Maekawa, M, Toyota, T, Iwayama, Y, Arai, M, Ichikawa, T, et al. Schizophrenia with the 22q11.2 deletion and additional genetic defects: case history. Br J Psychiatry 2011; 199: 245–6.CrossRefGoogle ScholarPubMed
4 Williams, HJ, Monks, S, Murphy, KC, Kirov, G, O'Donovan, MC, Owen, MJ. Schizophrenia two-hit hypothesis in velo-cardio facial syndrome. Am J Med Genet B Neuropsychiatr Genet 2013; 162: 177–82.Google Scholar
5 Girirajan, S, Rosenfeld, JA, Cooper, GM, Antonacci, F, Siswara, P, Itsara, A, et al. A recurrent 16p12. 1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet 2010; 42: 203–9.Google Scholar
6 Cullen, PJ. Endosomal sorting and signalling: an emerging role for sorting nexins. Nat Rev Mol Cell Biol 2008; 9: 574–82.Google Scholar
7 Wang, X, Zhao, Y, Zhang, X, Badie, H, Zhou, Y, Mu, Y, et al. Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome. Nat Med 2013; 19: 473–80.Google Scholar
8 Katoh, Y, Ritter, B, Gaffry, T, Blondeau, F, Höning, S, McPherson, PS. The clavesin family, neuron-specific lipid-and clathrin-binding Sec14 proteins regulating lysosomal morphology. J Biol Chem 2009; 284: 27646–54.Google Scholar
9 Lai, J-Y, Wu, P-C, Chen, H-C, Lee, M-B. Early neuropsychiatric involvement in antiphospholipid syndrome. Gen Hosp Psychiatry 2012; 34: 579.e1–3.CrossRefGoogle ScholarPubMed
10 McDonald-McGinn, DM, Fahiminiya, S, Revil, T, Nowakowska, BA, Suhl, J, Bailey, A, et al. Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS. J Med Genet 2013; 50: 80–90.Google Scholar
Supplementary material: PDF

Balan et al. supplementary material

Supplementary Material

Download Balan et al. supplementary material(PDF)
PDF 616.2 KB
Submit a response

eLetters

No eLetters have been published for this article.